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============

Behavioral and psychological symptoms of dementia (BPSD) are known predictors of institutionalization \[[@CR1]--[@CR3]\], lower quality of life \[[@CR4]\], and caregiver distress \[[@CR5], [@CR6]\]. Guidelines recommend initial management with non-pharmacological means \[[@CR7]\], but antipsychotic drugs are widely used for the treatment of certain BPSD. One study showed that 40 % of elderly people with cognitive impairment in nursing homes took antipsychotic drugs \[[@CR8]\]. The widespread use of antipsychotic drugs in nursing homes has been a concern for many years. Safety data from randomized clinical trials and observational studies have led regulatory agencies to issue official warnings on a possible increased risk of ischemic cerebrovascular events and all-cause death associated with the use of antipsychotics \[[@CR9], [@CR10]\]. Despite US Food and Drug Administration (FDA) safety warnings, there has been little change in the rate of antipsychotic prescription in US nursing homes over the past decade \[[@CR11]--[@CR15]\]. On the other hand, there have been updates regarding the off-label use of atypical antipsychotics for BPSD \[[@CR16]\], such as the comparative effectiveness reviews issued by the Agency for Healthcare Research and Quality in the USA \[[@CR17]\]. There were small but statistically significant benefits from using aripiprazole, olanzapine, and risperidone compared with placebo in the treatment of BPSD \[[@CR17]\]. Although the use of antipsychotics in BPSD is off-label, antipsychotics are still the best pharmacological short-term treatment option for BPSD-related aggression/agitation \[[@CR16]\].

There is wide variation across Organization for Economic Co-operation and Development (OECD) countries in the provision of formal long-term care (LTC) services for the elderly. A common concern has been the quality of formal LTC services, particularly in nursing homes \[[@CR18], [@CR19]\]. Nursing homes, themselves, involve a heterogeneous range of resident cases and services rendered, often based on country and setting \[[@CR20]\]. The use of antipsychotics is considered an indicator of quality of care in nursing homes. Though nursing homes play an important role in providing care for the elderly, no data are currently available on the use of psychoactive medications in Korea nursing homes.

The aim of this study was to describe the pattern of use of antipsychotic drugs in Korean nursing home residents with dementia and to identify individual sociodemographic and clinical characteristics and facility-related factors that are associated with their use.

Methods {#Sec2}
=======

The sample data for this retrospective, cross-sectional analysis was derived from the Long-term care of Old people Via KorEan nursing home network (LOVE) study, conducted in 20 Korean LTC facilities from October 2011 to April 2012. A total of 835 residents were recruited from 20 nursing homes. Of these, 41 patients were excluded due to incomplete data and 265 patients due to no diagnosis of dementia. The study was approved by the Ethics Review Board at Myoung-Ji Hospital.

Comprehensive assessment, including medical, psychosocial, and functional evaluation, was performed by a geriatrics team \[[@CR21]\]. The following variables were included in the analysis: gender, age (years), grade of long-term care (Grade 1 = greater dependency and the requirement for high-level care), and history of co-morbidities such as hypertension, stroke, diabetes mellitus, osteoporosis, Parkinson's disease, and congestive heart failure. All medical diagnoses, including dementia, were made by the physicians in charge of the resident, following the usual International Classification of Diseases diagnostic criteria. BPSD was determined using the Neuropsychiatric Inventory-Questionnaire (NPI-Q) assessment tool, and associations with the use of antipsychotic drugs were investigated. The NPI Questionnaire is a validated caregiver-completed questionnaire derived from the original NPI. The NPI-Q is used to measure 12 categories of behavioral disturbance: delusions, hallucinations, anxiety, depression/dysphoria, agitation/aggression, elation/euphoria, disinhibition, irritability/lability, apathy/Indifference, motor disturbance, night-time behavior problems, and problems with appetite/eating. The questionnaire is completed by a caregiver and determines whether the patient exhibits each of the behaviors \[[@CR22]\]. Drugs were classified according to the Anatomical Therapeutic Chemical (ATC) classification system \[[@CR23]\]. Psychotropic drugs were categorized as follows: any psychotropic (ATC-codes N05 and N06), antipsychotics (N05A), anxiolytics (N05B), hypnotics (N05C), and antidepressants (N06A).

Resident baseline characteristics were described using *t* tests for continuous variables and Chi-square tests for categorical variables. NPI-Q characteristics were described according to the use of antipsychotic drugs, and differences in these characteristics were identified by Chi-square tests. To examine factors associated with antipsychotic drug use, multiple logistic regression analysis was performed. The dependent variable was the antipsychotic drug use, and the independent predictors were age, sex, the grade of long-term care, the length of stay, and other drugs. All analyses were conducted using SPSS 18.0 software for Windows.

Results {#Sec3}
=======

Table [1](#Tab1){ref-type="table"} shows the baseline characteristics of residents with dementia. The mean age of the total 529 dementia residents was 81.16 ± 8.73 years (mean ± SD), and 410 (77.5 %) of the residents were female. The average length of stay in long-term care facilities was 24.19 ± 23.06 months. In the 143 (27 %) residents currently using antipsychotics \[quetiapine (N05AH04), risperidone (N05AX08), and olanzapine (N05AH03)\], the most commonly prescribed medication in these residents; 25.9 % were taking an anti-dementia drug \[donepezil (N06DA02), memantine (N06DX01), and other\].Table 1Demographic and baseline characteristics of nursing home residents with dementiaCharacteristics*n* (%)Demographic characteristics Age (mean ± SD), years81.16 ± 8.73 Sex  Male119 (22.5)  Female410 (77.5)Resident characteristics Grade of long-term care  169 (13)  2167 (31.6)  3293 (55.4) Length of stay (mean ± SD), months24.19 ± 23.06 Clinical problems  Hypertension343 (64.8)  Stroke167 (31.6)  Diabetes mellitus134 (25.3)  Osteoarthritis84 (15.9)  Osteoporosis66 (12.5)  Parkinson's disease34 (6.4)  Heart failure12 (2.3) Medications  Antipsychotics (N05A)143 (27.0)   Quetiapine (N05AH04) 120 (22.7)   Risperidone (N05AX08)25 (4.7)   Olanzapine (N05AH03) 21 (4.0)   More than two drugs23 (4.3)  Anti-dementia drugs (N06D)   Donepezil (N06DA02)97 (18.3)   Memantine (N06DX01)30 (5.7)   Other10 (1.9)  Antidepressants (N06A)   Selective serotonin reuptake inhibitor (N06AB)14 (2.6)   Trazodone (N06AX05)27 (5.1)   Tricyclic antidepressant (N06AA)10 (1.9)   Other10 (1.9)  Anticonvulsants (N03A)24 (4.5)  Anxiolytics (N05BA)22 (4.2)*Grade 1* greater dependency and the requirement for high-level care

Tricyclic antidepressants, which are inappropriate in dementia because of anticholinergic vulnerability, were prescribed in 10 (1.9 %) residents. Agitation (51.2%) was one of the most common of the behavioural and psychological symptoms of dementia (see Table [2](#Tab2){ref-type="table"}). Of the residents taking an anti-dementia drug, 69.7 % were taking quetiapine, 14.5 % risperidone, and 15.8 % olanzapine (Table [3](#Tab3){ref-type="table"}). Disinhibition and irritability were associated with the use of antipsychotics in a multiple logistic regression analysis. Indeed, the multiple logistic regression analysis showed that those who exhibited disinhibition and irritability were at increased risk of being prescribed an antipsychotic drug (Table [4](#Tab4){ref-type="table"}).Table 2Prevalence of behavioral and psychological symptoms of dementia (BPSD) stratified by antipsychotic drug useBPSDNo antipsychotic medication, *n* = 386 (%)^a^Antipsychotic medication,^(b)^ *n* = 143 (%)^(a)^*P* value^c^Delusions142 (36.8)45 (31.5)0.256 Severity2.11 ± 0.762.13 ± 0.840.836 Distress2.8 ± 1.362.73 ± 1.440.790Hallucinations104 (26.9)44 (30.8)0.384 Severity2.25 ± 0.792.27 ± 0.760.859 Distress2.81 ± 1.473.11 ± 1.470.250Agitation205 (53.1)66 (46.2)0.155 Severity2.27 ± 0.792.30 ± 0.840.788 Distress2.98 ± 1.403.04 ± 1.570.749Depression199 (51.6)75 (52.4)0.855 Severity2.06 ± 0.751.93 ± 0.830.226 Distress2.41 ± 1.322.21 ± 1.340.281Anxiety107 (27.7)40 (28.0)0.954 Severity1.99 ± 0.811.95 ± 0.750.782 Distress2.36 ± 1.452.45 ± 1.400.720Euphoria99 (25.6)36 (25.2)0.912 Severity1.87 ± 0.651.97 ± 0.770.438 Distress1.99 ± 1.271.83 ± 1.480.545Apathy137 (35.5)46 (32.2)0.475 Severity2.66 ± 0.732.00 ± 0.820.047 Distress2.64 ± 1.382.07 ± 1.220.012Disinhibition155 (40.2)36 (25.2)0.001 Severity2.23 ± 0.752.39 ± 0.650.246 Distress2.93 ± 1.463.06 ± 1.410.637Irritability178 (46.1)48 (33.6)0.010 Severity2.18 ± 0.802.38 ± 0.760.130 Distress2.79 ± 1.432.90 ± 1.420.656Aberrant motor behavior123 (31.9)43 (30.1)0.693 Severity2.30 ± 0.752.42 ± 0.630.355 Distress3.11 ± 1.392.72 ± 1.320.115Night-time behavior155 (40.2)52 (36.4)0.427 Severity2.25 ± 0.742.35 ± 0.620.406 Distress3.05 ± 1.392.75 ± 1.330.182Appetite/eating behavior73 (18.9)18 (12.6)0.087 Severity2.01 ± 0.741.94 ± 0.800.726 Distress2.21 ± 1.351.89 ± 1.570.391^a^Values are presented as *n* (%) for prevalence of BPSD, mean ± SD for severity and distress^b^Prescribed antipsychotic medications were quetapine, risperidone, and olanzapine^c^ *P* value from Chi-square test for prevalence of BPSD, *t* test for severity and distressTable 3Prevalence of antipsychotic use in dementia patients stratified by anti-dementia drug useDonepezil (N06DA02)Memantine (N06DX01)Other drugsNo antidementia drug useQuetiapine (N05AH04) 31 (25.8)16 (13.3)6 (5.0)67 (55.8)Risperidone (N05AX08)6 (24.0)3 (12.0)2 (8.0)14 (56.0)Olanzapine (N05AH03) 7 (33.3)5 (23.8)09 (42.9)Values are presented as *n* (%)Table 4Logistic regression analysis for antipsychotic use in long-term care facility residents with dementiaBPSD^a^*β*Standard error*P* valueAdjusted OR^b^ (95 % CI^c^)Delusions−0.2540.2380.2860.78 (0.48--1.24)Hallucinations0.2870.2440.2391.33 (0.83--2.15)Agitation−0.1060.2250.6370.90 (0.58--1.40)Depression0.1670.2250.4571.18 (0.76--1.83)Anxiety−0.7600.2520.7630.93 (0.57--1.52)Euphoria0.2290.2530.3641.26 (0.77--2.07)Apathy0.0440.2350.8501.05 (0.66--1.66)Disinhibition−0.6730.2470.0070.51 (0.31--0.83)Irritability−0.5630.2330.0160.57 (0.36--0.90)Aberrant motor behavior−0.0450.2420.8540.96 (0.60--1.54)Night-time behavior−0.1520.2300.5080.86 (0.55--1.35)Appetite/eating behavior−0.5720.3280.0810.56 (0.30--1.07)Adjusted for age, sex, grade of long term care, and length of stay^a^Behavioral and psychological symptoms of dementia^b^Odds ratio^c^Confidence interval
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A diagnosis of dementia was present in 63.3 % of 835 residents in 20 long-term care facilities in Korea, and 27.0 % of these residents had been prescribed an antipsychotic drug. A previous study showed that of 1334 non-agenarian residents in long-term care, 30 % has been prescribed an antipsychotic medication \[[@CR24]\]. In 2005, Hosia-Randell and Pitkälä \[[@CR25]\] stated that 31.3 % of non-agenarian residents in nursing homes in Helsinki were taking antipsychotics. The present results are also in agreement with the earlier findings of studies by Oborne (24.5 %) \[[@CR26]\] and Briesacher (27.6 %) \[[@CR12]\].

A number of limitations must be mentioned with regard to the present study. First, the study was cross-sectional, thus providing a comprehensive snapshot at one point in time but without the ability to establish causal relationships. Second, the facilities included in the study were not randomly selected. As such, they may not be nationally representative or generalizable to all long-term care residents in Korea. There is also a possibility of selection bias as geriatricians may have a tendency to prescribe antipsychotic drugs or that patients with more severe BSPD are primarily admitted to facilities in which such a geriatrician was known to be available. Nevertheless, the strengths of this work should not be overlooked. The study included a relatively large sample to illustrate current antipsychotic use in Korean nursing homes.

Behavioral symptoms and dementia have previously been shown to be the main predictors of antipsychotic prescriptions in nursing home residents \[[@CR27], [@CR28]\] and the results of our study support this finding. Continuous prescription of antipsychotics here and in another study \[[@CR29]\] is not concordant with current treatment recommendations, and the need for continued treatment should be reviewed regularly every 6 months \[[@CR30]--[@CR32]\]. On the other hand, antipsychotics showed small but statistically significant benefits in the treatment of BPSD and are still the short-term pharmacological treatment option for BPSD associated with disinhibition and irritability in long-term care facilities in Korea.

Conclusion {#Sec5}
==========

BPSD are common in long-term care facilities in Korea. Twenty-seven percent of dementia residents in long-term care facilities in Korea were prescribed antipsychotic medications. Furthermore, antipsychotic drug use was significantly associated with disinhibition and irritability in those patients.
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